Literature DB >> 17139123

Acute liver dysfunction complicated with uncontrollable glycemia due to insulin antibody: successful treatment with glucocorticoid and lispro insulin.

Munehiro Honda1, Yumi Kawashima, Hiroko Kawamura, Hirotoshi Fujikawa, Kentaro Kikuchi, Hiroshi Ohashi, Yasumichi Mori, Hiroshi Miyakawa, Miyuki Ishibashi.   

Abstract

Here, we report a case of acute liver dysfunction complicated with uncontrollable glycemia due to insulin antibody. The patient was admitted to our hospital due to diabetic ketoacidosis. He was administered insulin immediately, however, his fasting plasma glucose level remained unstable despite the insulin treatment. Blood biochemistry revealed severe liver dysfunction, although no markers including hepatitis virus or autoantibodies associated with autoimmune liver diseases were detected. The 125I-insulin binding rate was high (54%). The characteristics of insulin antibody in this patient were similar to the antibodies of IAS patients, therefore we administered oral glucocorticoid against insulin antibody. The reduction in the 125I-insulin binding rate and the binding capacity of the high affinity site of insulin antibodies were balanced after oral glucocorticoid therapy. In addition, preprandial subcutaneous regular insulin was switched to lispro insulin. Postprandial plasma glucose levels were relatively improved by lispro insulin. The etiology of acute liver dysfunction was unknown, however, we believe that the combination of oral glucocorticoid and lispro insulin was suitable and useful for preventing recurrent liver dysfunction in this patient.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139123     DOI: 10.2169/internalmedicine.45.6009

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Glycated albumin (GA) and the GA/HbA1c ratio are higher in diabetic patients positive for insulin antibodies with high binding capacity and low affinity.

Authors:  Takehito Takeuchi; Yushi Hirota; Yasushi Nakagawa; Atsuko Matsuoka; Tetsushi Hamaguchi; Yuko Okada; Kazuhiko Sakaguchi; Wataru Ogawa; Masafumi Koga
Journal:  Diabetol Int       Date:  2021-08-18

Review 2.  Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients.

Authors:  Xiaolei Hu; Fengling Chen
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

3.  Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat.

Authors:  Takumi Komiya; Akihiro Mori; Naohito Nishii; Hitomi Oda; Eri Onozawa; Seri Seki; Toshinori Sako
Journal:  J Vet Med Sci       Date:  2021       Impact factor: 1.267

4.  Recurrent Hypoglycemia Due to a High Titer of Insulin Antibody in Response to Exogenous Insulin Administration in Two Cases of Type 1 Diabetes.

Authors:  Ryoichi Kawamura; Satoshi Miyao; Hiroshi Onuma; Yasuko Uchigata; Eiji Kawasaki; Jun Ohashi; Sanshiro Shiraishi; Wataru Nishida; Maki Yokomoto-Umakoshi; Yasunori Takata; Haruhiko Osawa; Hideichi Makino
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.